Unveiling Insights into the Oligonucleotide Synthesis Market: Predicted to Cross USD 26.099 Billion by 2030

Oligonucleotide Synthesis Market

The oligonucleotide synthesis market is segmented on the basis of product, application, end user, and region.

PORTLAND, OREGON, UNITED STATES, February 13, 2024 /EINPresswire.com/ -- Allied Market Research recently published a report, titled, "Oligonucleotide Synthesis Market by Product (Oligonucleotide-Based Drugs, Synthesized Oligonucleotides, Reagents, and Equipment), Application (Therapeutic Applications, Research Applications, and Diagnostic Applications) and End User (Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs and CMOs, Academic Research Institutes): Global Opportunity Analysis and Industry Forecast, 2021–2030".

As per the report, the global oligonucleotide synthesis industry was pegged at $5.19 billion in 2020, and is expected to reach $26.09 billion by 2030, growing at a CAGR of 17.1% from 2021 to 2030.

𝑹𝒆𝒒𝒖𝒆𝒔𝒕 𝑺𝒂𝒎𝒑�.𝒆 𝑪𝒐𝒑𝒚 𝒐𝒇 𝑹𝒆𝒑𝒐𝒓𝒕 www.alliedmarketresearch.com/request-sample/8721

Major market players

Alnylam Pharmaceuticals, Inc.
Danaher Corporation
Biogen Inc.
Ionis Pharmaceuticals, Inc.
Eurofins Scientific
LGC Limited
Kaneka Corporation
Sarepta Therapeutics, Inc.
Merck KGAA
Thermo Fisher Scientific, Inc.

𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐎𝐟 𝐓𝐡𝐞 𝐒𝐭𝐮𝐝𝐲

Based on product, the oligonucleotide-based drugs held the largest share in the global market in 2020.
On the basis of application, the therapeutic application held the largest market share in 2020, and is expected to remain dominant throughout the forecast period.
By end user, the hospitals segment held the largest market share in 2020, and is expected to remain dominant throughout the forecast period.
Based on region, North America is expected to experience growth at the highest rate, registering a CAGR of 16.00% during the forecast period.

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧
Segmented by application, the oligonucleotide synthesis market encompasses therapeutic, research, and diagnostic applications. Leading the pack, therapeutic applications are expected to seize the lion's share of revenue in 2020 and maintain this momentum with a projected CAGR of 16.70% throughout the forecast period. This surge is underpinned by the burgeoning research in therapeutic applications.

Furthermore, the market is categorized by end-user into hospitals, pharmaceutical and biotechnology companies, diagnostic laboratories, Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs), and academic research institutes. Notably, hospitals took the helm of the global market in 2020, and this dominance is poised to persist in the forecast period.

𝐇𝐚𝐯𝐞 𝐀𝐧𝐲 𝐐𝐮𝐞𝐫𝐲? 𝐀𝐬𝐤 𝐎𝐮𝐫 𝐄𝐱𝐩𝐞𝐫𝐭 @ https://www.alliedmarketresearch.com/purchase-enquiry/A08356

This stronghold is attributed to the substantial volume of inpatient and outpatient visits to hospitals, coupled with the escalating demand for oligonucleotide drugs to address the needs of patients grappling with rare diseases, neurological disorders, and infectious diseases.

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐃𝐨𝐦𝐚𝐢𝐧-
𝐒𝐨𝐟𝐭𝐠𝐞𝐥 𝐂𝐚𝐩𝐬𝐮𝐥𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/softgel-capsules-market-A16306
𝐒𝐩𝐞𝐞𝐜𝐡 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/speech-therapy-market-A31451

David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.